Curr Med Res Opin 2009;25:2401-2411
Table 1 summarizes some nasal delivery devices with a brief description of the principles, dosage form, and limitations
As que, este primer anlogo del GLP-1 oral, adems de ser una nueva y nica opcin arGLP-1 para tratar la diabetes sin inyecciones, podra representar un nuevo estndar para el tratamiento de la diabetes tipo 2 3 , afirma Francisco Pajuelo, director mdico de Novo Nordisk Espaa
For type 2 diabetes, NICE recommends GLP-1 agonists when other treatments haven't achieved target HbA1c levels, with specific consideration for cardiovascular and renal risk factors according to NICE guideline NG28
In rare, severe cases that significantly impact vision, surgery that removes and replaces the vitreous may be considered (Mayo Clinic 2012)
About Lambda Lambda & Novum delivers full-service CRO services to the innovator, biotech, and generic pharmaceutical industries worldwide